Nasal Cavity Hemangiomas by Baki, Ahmet
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Nasal Cavity Hemangiomas
Ahmet Baki
Abstract
Hemangiomas are benign tumors originating from vascular structures in the 
body. Although it is common in the head and neck region, it is rarely seen in the 
nasal cavity and paranasal sinuses. Histologically, there are three types of heman-
giomas including capillary, cavernous, and mixed types, the most common being 
a cavernous hemangioma. Cavernous hemangiomas in the nasal cavity usually 
originate from the lateral nasal wall and cause symptoms such as nasal congestion 
and nosebleeds.
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1. Introduction
Vascular lesions in the head and neck region originate from blood vessels or 
lymphatics [1].
While the terminology used to describe vascular lesions was related to the clini-
cal appearance of the lesions rather than their physiopathological development, 
the first distinction that formed the basis of today’s classification was made by 
Mulliken and Glowacki in 1982 according to the clinical and histochemical findings 
and cell types [2].
Nasal hemangioma was first described by Poncet and Dor in 1897 as human 
botryomycosis. More than half of the hemangioma affects the head and neck 
region, rarely the nasopharynx. Therefore it is safe to presume that hemangioma in 
the nasal region is a rare disease [3].
Hemangiomas are common, benign endothelial lesions of the skin and mucous 
membranes. Hemangiomas have capillary, cavernous, mixed, and hypertrophic 
subtypes. Capillary hemangioma is the most common subtype and is mostly seen on 
anterior septal cartilage. Capillary hemangioma is seen mostly in the first years of 
life and may show spontaneous regression (Figure 1) [4, 6].
Cavernous hemangioma is seen mostly in adulthood, and traumatic etiology is 
present. Cavernous hemangioma is rare and seen in the bone septum or lateral nasal 
wall. On macroscopic examination, hemangiomas can be observed to have a polyp-
oid, smooth surface and a lobed pattern, whereas in the microscopic examination, 
it consists of capillaries covered with flat epithelium separated by collagen stroma. 
Cavernous hemangioma shows large proliferation of thin-walled blood vessels of 
various sizes covered with endothelium, while the mixed endothelial vascular areas 
form the large endothelium. These pathologies do not always differentiate from 
other forms of inflammatory pseudotumor (Figure 2) [5, 6].
Cavernous hemangiomas are uncommon in the paranasal sinuses and nose. It has 
been defined to originate from the inferior turbinate, vomer, lamina perpendicularis, 
and sinus maxillaris. Nasal mucosal hemangiomas ought to be distinguished from 
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hemangiomas that originate from the maxilla or nasal bones which are primary osseous 
lesions, of which the symptoms and surgical approach are entirely different [7–12].
Although nasal hemangiomas common in the head and neck region, it is uncom-
monly seen in the nasal mucosa. In the nasal cavity, the most common cause is the 
septum and the lateral nasal wall [13].
Although nasal hemangiomas commonly affect the anterior septum as described 
in prior literature, nasal hemangioma has also been reported in other nasal sites 
such as middle turbinates, inferior turbinates, posterior part of the septum, and 
vestibule [14].
Figure 2. 
Nasal septal cavernous hemangioma [6].
Figure 1. 
Capillary Hemangioma of the Nasal Septum [5].
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The most common symptom in hemangiomas located in the nasal cavity is nose 
bleeding; also other rare visible symptoms are nasal obstruction, runny nose, and 
epiphora [15]. Epistaxis and unilateral nasal obstruction were the most common 
presenting symptoms, followed by other nasal symptoms such as rhinorrhea. 
Epistaxis is the most common symptom, as demonstrated by previously published 
studies. In addition, extra nasal symptoms, such as facial pain and headache, are 
much less common [16].
In differential diagnosis, lymphangioma, venous hemangioma, angiofibroma, 
hemangioendothelioma, glomus tumor, and malignant nasal cavity tumors, meta-
static malignancies, Wegener granulomatosis, angiofibroma, and sinonasal papil-
loma should be kept in mind [3, 17].
The diagnosis of cavernous hemangioma can be made based on the patient’s 
history and clinical features of the lesion. Cavernous hemangiomas are tumors 
composed of vascular ectasia. They can be placed deeper in the skin, and mucous 
membranes additionally can involve deeper structures such as subcutaneous tissue, 
muscle, and bone. Hemangiomas may be localized in an area or may be common. 
All midline lesions such as subcutaneous cavernous hemangioma, nasal gliomas, 
meningocele or meningoencephaloceles, teratomas, sebaceous cysts, dermoid cysts, 
and fibromas, which have atypical clinical features in the nasal dorsum, should be 
differentiated [18].
Imaging tests such as ultrasonography (USG), computed tomography (CT), or 
magnetic resonance imaging (MRI) are needed to confirm vascular pathology and 
to demonstrate venous, arterial, or lymphatic components and whether deeper 
structures are involved. CT can be performed to exclude bone erosion or possible 
malignant transformations.
According to some authors, MRI is more effective in evaluating the connec-
tion with soft tissue and intracranial. Also, there is no radiation exposure. MRI is 
the first diagnostic tool that should be used for screening in patients with midline 
nasal mass. Negative results on imaging studies, even with contrast, do not exclude 
the intracranial communication. Phlebitis is typical for cavernous hemangiomas. 
Hypointense on T1-weighted images on MRI and hyperintense on T2 indicate the 
absence of coagulated blood [14, 19–22].
According to their histopathological appearance, it is possible to examine them 
as cavernous and capillary hemangiomas. They generally occur on the skin, and on 
the mucosal surfaces of the body, capillary hemangioma is a capillary ball that is 
located close to each other, separated by a connective tissue stroma [23]. Cavernous 
hemangiomas should be treated because they will never undergo involution [24].
Hemangiomas should be treated because they have the potential to cause bleed-
ing problems and complications such as infection in the head and neck, especially 
in the face, ear, and nose. Agents such as steroids, interferon, and vincristine may 
be used in the medical treatment of hemangiomas. The use of these agents is limited 
due to the large number of serious toxic side effects. Propranolol, which is a nonse-
lective beta blocker, was first introduced by Leaute-Lebeze, and it has been reported 
that it can be used safely in many later studies [25, 26].
Surgical excision is the treatment of choice for the treatment of nasal hem-
angiomas. Various surgical methods can be employed for this lesion such as 
excisional surgery, laser ablation, cryotherapy, and electrocoagulation. Surgical 
excision is a key for confirmation via histological examination and should be and 
remains the mode of choice of treatment for nasal hemangiomas. Surgical opera-
tion of cavernous hemangioma depends on the nature and localization of the 
lesion, but it should not cause functional and esthetic problems. All the patients 
can be successfully treated with adequate endoscopic surgical excision from the 
site of origin and no complications. Endoscopic resection of midline nasal tumors 
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without intracranial extension can be performed because external approaches 
cause postoperative esthetic problems. Tumor resection can be removed endo-
scopically, leaving a safe margin. Endoscopic technique provides better esthetic 
results. Sclerotherapy and laser are commonly used treatment modalities. 
Embolization with super-selective arteriography can be used in cases with arterial 
component or arteriovenous fistula [14, 18, 24].
Midline elliptical incision has good functional outcomes and maintains the nasal 
contours, although the surgical technique for these lesion outcomes marked a scar on 
the midline. Treated with inferior rhinotomy and achieved excellent results [27, 28].
Lesions in the nasal type region are easily accessible after incision where trans-
columellar and alarm rim incisions are combined, but it is difficult to reach larger 
and more complex lesions because the incision does not extend cranially [29]. 
A central wedge excision with vertical closure, removing excess skin, leads to a 
marked scar on the tip of the nose and columella, and as a result, it is recommended 
to avoid this wedge excision if possible [30].
Open rhinoplasty approach, and put forward that the extra skin will not be 
removed but rather left in place to let for contraction, which may take many 
months. In this approach, the excess skin remaining after the treatment of heman-
gioma can be considered as a disadvantage [31].
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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